Fundz

Infinitopes secures $15.4M in its Seed financing, totaling $35.1M, co-led by Octopus Ventures and Amplify Bio, to advance its cancer vaccine clinical trials.

PRIVATEJan 21, 2026

Amount Raised

$15.4 Million

Round Type

Seed

OxfordshireBiotechnologyHealth CareArtificial Intelligence

Investors

Macmillan Cancer SupportCancer Research HorizonsManta Ray VenturesOctopus VenturesAmplify Bio

Description

Infinitopes, a clinical-stage cancer vaccine biotechnology company, successfully completed its seed financing round, raising an additional $15.4 million. This funding will support the launch of its Phase I/IIa clinical trial for its precision therapeutic vaccine ITOP1. The trial aims to prevent recurrence in oesophageal cancer patients, addressing a critical need in the sector. With participation from notable investors, Infinitopes is positioned to lead in innovative cancer treatments.

Quick answer

Infinitopes raised $15.4 Million in a Seed round, dated January 21, 2026. Investors: Macmillan Cancer Support, Cancer Research Horizons, Manta Ray Ventures, Octopus Ventures and Amplify Bio. Infinitopes is based in Oxfordshire, England, United Kingdom.

How much did Infinitopes raise?
Infinitopes raised $15.4 Million in a Seed round on January 21, 2026.
Who invested in Infinitopes?
Macmillan Cancer Support, Cancer Research Horizons, Manta Ray Ventures, Octopus Ventures and Amplify Bio are named as investors in this round.
What does Infinitopes do?
Infinitopes is a pioneer in precision immunomics medicines.
Where is Infinitopes based and how big is it?
Infinitopes is based in Oxfordshire, England, United Kingdom. Fundz records about 26 employees.
Who are the decision-makers at Infinitopes?
Fundz holds 1 contact at Infinitopes. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Biotechnology and Health Care around the same time

Companies in the same sectors as Infinitopes that raised within 45 days of this round, from Fundz verified event records.

  • Qura raised $1.7M (Pre-Seed) on March 3, 2026.
  • Outpost Bio raised $3.5M (Pre-Seed) on March 2, 2026.
  • Procode AI raised $4M (Seed) on March 2, 2026.
  • TileBio raised $2.1M (Seed) on March 2, 2026.
  • Change Agents Corporation. raised $207K (Debt Financing) on February 25, 2026.
  • Puresta raised $3.7M (Pre-Seed) on February 24, 2026.

Who to call at Infinitopes, and when

A new round usually means Infinitopes is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Infinitopes raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Infinitopes, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Infinitopes. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Infinitopes

Location

Oxfordshire, England, United Kingdom

About

Infinitopes is a pioneer in precision immunomics medicines. A Cancer Research UK (CRUK)-led biotech spinout from Oxford University, we are empowering the immune system to fight cancer metastases with unique, de novo antigen discovery technologies, innovative high efficiency vectors and intelligent clinical trial design. Our mission is to significantly enhance patient survival.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Infinitopes raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Infinitopes's next move

See what Strategic adds

Infinitopes raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.